what does the glp 1 receptor do Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Evolution of GLP‐1 Receptor Agonists
Description
Anegawa acknowledges that tapering off of medication is under active study and there isnt research available to show when a person can get off a GLP-1 and successfully maintain weight loss
Hashimoto K, ed
DIABETES DRUGS Market Overview, by Route Of Administration Segment 67 15.1.1
At 12 months, weight loss persisted at around 4%, with variability between agents, most notably liraglutide
This table is a reference starting point
Even with a PTE, the math rarely works in favor of the innovator
